Telomerase activity in human urothelial tumors

American Journal of Clinical Pathology

Volumn 107, Issue 5, 1997, Pages 555-560

  Kyo, Satoru ^a   Kunimi, Kazuto ^a   Uchibayashi, Tadao ^a   Namiki, Mikio ^a   Inoue, Masaki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Immortalization; Telomerase; Telomere; Telomeric repeat amplification protocol; Urothelial tumor

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CELL IMMORTALIZATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY PELVIS CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; URETER CANCER; UROGENITAL TRACT TUMOR;

EID: 0030979090     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/107.5.555     Document Type: Article

References (19)

1. Rhyu MS. Telomeres, telomerase and immortality. J Natl Cancer Inst. 1995;87:884-894.
2. Olovnikov AM. A theory of marginotomy: The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol. 1973;41:181-190.
3. Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature. 1989;337:331-337.
4. Yu GL, Bradley JD, Attardi LD, et al. In vivo alteration of telomerase sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature. 1990;344:126-132.
5. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA. 1992;89:10,114-10,118.
6. Vaziri H, Dragowska W, Allsopp RC, et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA. 1994;91:9857-9860.
7. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992;11:1921-1929.
8. Counter CM, Hirte HW, Bacchetti S, et al. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA. 1994;91:2900-2904.
9. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
10. Chadeneau C, Hay K, Hirte HW, et al. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 1995;55:2533-2536.
11. Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res. 1995;55:3258-3262.
12. Hiyama K, Hiyama E, Ishioka S, et al. Telomerase activity in small cell and non-small cell lung cancers. J Natl Cancer Inst. 1995;87:895-901.
13. Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst. 1996;88:116-122.
14. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinoma. Cancer Res. 1995;55:2734-2736.
15. Lin Y, Miyamoto H, Fujinami K, et al. Telomerase activity in human bladder cancer. Cancer Res. 1996;2:929-932.
16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
17. Kyo S, Ueno H, Kanaya T, et al. Telomerase activity in gynecological tumors. Clin Cancer Res. 1996;2:2023-2028.
18. Murnane JP, Sabatier L, Marder BA, et al. Telomerase dynamics in an immortal human cell line. EMBO J. 1994;13:4953-4962.
19. Bryan TM, Englezou A, Gupta J, et al. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 1995;17:4240-4248.